Long Island Researcher`s Clinical Trial Targets Lupus Pain

Dr. Cynthia Aranow, a medical investigator at the Feinstein Institute for Medical Research has been working closely with Dr. Kevin Tracey of the Feinstein Institute on a possible major breakthrough in lupus pain research. Dr. Aranow, is a long-time board member of the Lupus Alliance of LIQ and a staunch supporter of the LALIQ`s programs… Read More »

New York Lupus Advocates Celebrate Legislative Victory

The Lupus Agencies of New York State (LANYS) recently announced another victory after Gov. Andrew Cuomo signed into the law the Lupus Education and Outreach Bill. The new legislation will bring essential lupus education to the public and to health professionals. The bill was passed unanimously in June by the New York State Senate and the state… Read More »

The Lupus Alliance of Long Island/Queens Hails a Huge Lupus Advocacy Victory With the Passing of the 21st Century Cures Act

The Lupus Alliance of Long Island/Queens Hails a Huge Lupus Advocacy Victory With the Passing of the 21st Century Cures Act Legislation will bring essential lupus education to the public and health professionals The Lupus Alliance of Long Island/Queens, the only lupus agency located on Long Island that is dedicated to helping those who live… Read More »

Xencor Highlights Potential Lupus Therapy Now in Phase 2 Testing

During the recent Analyst Day event in New York, Xencor highlighted its lead candidate to treat systemic lupus erythematosus (SLE), now in Phase 2 clinical testing, and other potential treatments advancing in development. “We believe our flexible bispecific oncology platform has substantial potential. Our programs are built on a novel XmAb Fc domain, which allows for the rapid… Read More »

Mouse Study Points Way to Shut Down Harmful Immune Response in Lupus

Molecules that scavenge debris from dying cells appear to halt the cycle of chronic inflammation in lupus, while also enhancing the body’s ability to combat flu, according to Duke Health studies in mice. The molecules, called polymers, have commonly been used in gene-transfer experiments because they bind to the nucleic acid in DNA and RNA.… Read More »

Temple University Scientists Make Breakthrough in Lupus Research

In a press release issued on July 6, 2015, researchers at Temple University School of Medicine (TUSM) announced a breakthrough in the study of systemic lupus erythematosus, an autoimmune disease which causes the immune system to attack DNA and RNA molecules. The discovery, headed by researchers Çagla Tükel and Stefania Gallucci, found that biofilm — or bacterial… Read More »

Disease Activity in Pediatric Lupus Nephritis May Possibly Be Monitored with Urine Biomarkers

Researchers have discovered a potential new noninvasive measurement for the management of lupus nephritis in pediatric and young adult patients that may help not only keep track of disease progression but also monitor therapeutic responses. The study, “Development of a Novel Renal Activity Index of Lupus Nephritis in Children and Young Adults,” was published in the… Read More »

Autoantibodies Could Help Treat Lupus, Other Autoimmune Diseases

Autoantibodies that naturally occur in patients with an ultra-rare type of autoimmune disorder called autoimmune polyendocrine syndrome type 1 (APS1 or APECED), could help fight lupus and other diseases. The study, “AIRE-Deficient Patients Harbor Unique High-Affinity Disease-Ameliorating Autoantibodies,” was conducted by scientists at ImmunoQure AG, a German biotechnology company, in collaboration with a group of academic researchers… Read More »

$335K Grant Supports Chronic Disease Management for Lupus

A $335,000 grant from the HHS Office of Minority Health will help the American College of Rheumatology (ACR) strengthen its chronic disease management programs for patients with lupus, the organization announced this week. The Lupus Initiative, a national educational program intended to improve quality of life and outcomes for patients with the autoimmune disease, has… Read More »